Hikma slips after Barclays downgrades stock

Hikma Pharmaceuticals

07/01/2026 11:58

** Shares of Hikma Pharmaceuticals HIK.L down 1.3% at 1,546 pence at 1130 GMT

** Barclays cuts its rating on stock to "underweight" from "equal weight"

** Brokerage also cuts target price to 1,600p from 2,100p

** 10 of 12 analysts covering the stock have a "buy" or higher rating, one has "hold", while one "sell"; Median PT 2,360p, according to data compiled by LSEG

** Stock fell roughly 22% in 2025

(Reporting by Neeshita Beura in Bengaluru)

((Neeshita.Beura@thomsonreuters.com))